JV Heads South And Invests £200M In New West London Life Sciences Scheme

Courtesy of Bruntwood SciTech/Jason Hawkes
Imperial's Deep Tech Campus In White City

A major investor and developer in the north-west and Midlands life sciences real estate sector is investing £200M in a major new scheme in west London, its first project in the capital.

Bruntwood SciTech is a joint venture between property company Bruntwood, institutional investor L&G and the Greater Manchester Pension Fund. It has teamed up with Imperial College and will build a 200K SF lab and office scheme on land owned by Imperial in the White City area of west London

The project was described as a £200M initial investment, and the JV and Imperial could undertake further projects together.

Valued at £1.5B, Bruntwood SciTech has a portfolio of 5.2M SF across 11 campus locations and 31 city centre locations in Manchester, Cheshire, Birmingham, Leeds, Liverpool, Cambridge and now London. It has plans to create a £5B portfolio by 2033 and has a 2.3M SF secured development pipeline.

The new building will be part of Imperial’s White City Deep Tech Campus, which provides research facilities for academics alongside space and support for early-stage companies. It includes about 1.5M SF of research, office and lab space. Student accommodation has already been built there, providing housing for more than 5,000 staff and students.

The new innovation centre will ultimately form part of Imperial’s £2B investment at the campus, of which a third has already been delivered. Construction is anticipated to start in 2026.

“The White City Campus is a hugely ambitious project that will help propel the UK to the forefront of innovation,” Bruntwood SciTech Chief Scientific Officer Kath Mackay said in a statement.

“Having worked to become deeply embedded in the knowledge economies of the UK’s leading regional cities and creating successful city-wide innovation ecosystems, it is now the perfect time for us to expand into London,” Mackay said.

“This new, joined up approach between the capital and the UK’s fastest growing regional cities will enable businesses to harness the power of the collective and encourage companies of all sizes to consider the UK as their first choice for future investment.”

Continue reading this story with a free account

Log in or register

Bisnow’s Beyond Biotech: UK Life Sciences Forecast event is being held in London on 3 December, with speakers from GSK, Brockton Everlast, the University of Oxford and Mission Street.

Sign up for more articles like this
Subscribe to Bisnow's London Newsletters
Related Stories

UK Budget Risks Deterring Sovereign Wealth Funds From Real Estate

TPG, ACORE Raise Billions For Opportunistic CRE Funds

Newmark Cuts Earnings Outlook Despite Record Third Quarter

Battered Mortgage REIT Suspends Dividend To Preserve Cash

Gwinnett Mall Project Stands To Benefit From Georgia's Opportunity Zone Picks

Blackstone Mortgage Trust Reports Unexpected Q3 Net Loss

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

Tyko Capital Sets New Record For Florida's Largest Construction Loan

Deutsche Bank's Asset Manager Needs To Sell To Meet Redemptions. Here's What It Owns

JLL's Q3 Revenue Surges Amid Strong Leasing, Capital Markets Activity

Fed's Pause Gives CRE Little Relief As Yields, Midterms Freeze Deals

Prologis To Develop 3.8M SF Industrial Park On Former Casino Site